Treatment of HER2+ breast cancer: a retrospective of disease prognosis with loss of HER2 amplification on residual disease after neoadjuvant treatment in a community hospital setting.
Am J Cancer Res
; 13(6): 2564-2571, 2023.
Article
em En
| MEDLINE
| ID: mdl-37424818
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article